1. Home
  2. EVEX vs PVLA Comparison

EVEX vs PVLA Comparison

Compare EVEX & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eve Holding Inc.

EVEX

Eve Holding Inc.

HOLD

Current Price

$4.81

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Logo Palvella Therapeutics Inc.

PVLA

Palvella Therapeutics Inc.

HOLD

Current Price

$101.65

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVEX
PVLA
Founded
2020
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
EVEX
PVLA
Price
$4.81
$101.65
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
16
Target Price
$6.88
$141.50
AVG Volume (30 Days)
1.8M
319.7K
Earning Date
11-04-2025
11-11-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.83
$11.17
52 Week High
$7.70
$112.00

Technical Indicators

Market Signals
Indicator
EVEX
PVLA
Relative Strength Index (RSI) 59.48 57.96
Support Level $4.58 $84.25
Resistance Level $5.16 $112.00
Average True Range (ATR) 0.31 7.15
MACD 0.01 -0.75
Stochastic Oscillator 64.52 57.87

Price Performance

Historical Comparison
EVEX
PVLA

About EVEX Eve Holding Inc.

Eve Holding Inc is a provider of Urban Air Mobility solutions. The company's operating segments are; eVTOL that includes; the design and production of electric vertical take-off and landing vehicles (eVTOLs) including fixed wing and helicopter operators, as well as lessors that purchase and manage aircraft on behalf of operators; Service and Operations Solutions segment which includes a portfolio of maintenance and support services focused on its and third-party eVTOLs; and the UATM segment , a new Urban Air Traffic Management system designed to allow eVTOLs to operate safely and efficiently in dense urban airspace alongside conventional aircraft and drones.

About PVLA Palvella Therapeutics Inc.

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.

Share on Social Networks: